2023 Q1 Form 10-K Financial Statement

#000149315223009418 Filed on March 29, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $993.00 $2.670K $2.671K
YoY Change 231.0% 1235.0% 1235.5%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.548K $672.3K $24.80K
YoY Change -98.71% -22.47% -97.14%
% of Gross Profit
Research & Development $0.00
YoY Change -100.0%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $97.71K $685.0K $685.0K
YoY Change -35.42% -35.42%
Operating Profit -$96.71K -$682.3K
YoY Change -64.95% -35.66%
Interest Expense -$59.80K -$83.41K -$83.41K
YoY Change 570.4% 299.09% 299.09%
% of Operating Profit
Other Income/Expense, Net -$59.80K -$296.7K
YoY Change 121.43%
Pretax Income -$156.5K -$979.1K -$979.1K
YoY Change -48.33% -9.99% -9.99%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$156.5K -$979.1K -$979.0K
YoY Change -48.33% 96.86% -9.99%
Net Earnings / Revenue -15761.63% -36668.54% -36654.74%
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share $0.00 -$0.01 -$0.01
COMMON SHARES
Basic Shares Outstanding 119.7M shares 115.0M shares
Diluted Shares Outstanding 119.8M shares 98.65M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.67K $4.070K $4.070K
YoY Change -64.52% -92.5% -92.5%
Cash & Equivalents $18.67K $4.067K
Short-Term Investments
Other Short-Term Assets $31.85K $53.81K $53.81K
YoY Change -77.05% -74.4% -74.4%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $50.51K $57.88K $57.88K
YoY Change -73.61% -78.12% -78.12%
LONG-TERM ASSETS
Property, Plant & Equipment $451.9K $283.2K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $451.9K $283.2K $283.2K
YoY Change 311.27%
TOTAL ASSETS
Total Short-Term Assets $50.51K $57.88K $57.88K
Total Long-Term Assets $451.9K $283.2K $283.2K
Total Assets $502.5K $341.1K $341.1K
YoY Change 66.77% 28.97% 28.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $41.04K $56.32K $56.32K
YoY Change -48.73% 29.29% 29.29%
Accrued Expenses $59.07K $47.74K $47.74K
YoY Change 79.87% 80.7% 80.7%
Deferred Revenue $0.00 $0.00
YoY Change
Short-Term Debt $185.0K $185.0K $185.0K
YoY Change -15.91% -5.13% -5.13%
Long-Term Debt Due $60.01K $4.710K $4.710K
YoY Change 4217.27%
Total Short-Term Liabilities $345.1K $293.8K $293.8K
YoY Change -47.78% 10.86% 10.86%
LONG-TERM LIABILITIES
Long-Term Debt $30.36K $30.36K $30.36K
YoY Change -71.75% -12.13% -12.13%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $30.36K $30.36K $30.36K
YoY Change -88.79% -12.12% -12.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $345.1K $293.8K $293.8K
Total Long-Term Liabilities $30.36K $30.36K $30.36K
Total Liabilities $375.5K $324.1K $324.1K
YoY Change -59.7% 8.21% 8.21%
SHAREHOLDERS EQUITY
Retained Earnings -$7.390M -$7.233M
YoY Change 15.65%
Common Stock $120.2K $119.1K
YoY Change 43.91%
Preferred Stock
YoY Change
Treasury Stock (at cost) $50.00K $50.00K
YoY Change
Treasury Stock Shares
Shareholders Equity $127.0K $16.99K $16.99K
YoY Change
Total Liabilities & Shareholders Equity $502.5K $341.1K $341.1K
YoY Change 66.77% 28.97% 28.97%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$156.5K -$979.1K -$979.0K
YoY Change -48.33% 96.86% -9.99%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$90.70K -$32.20K -$372.0K
YoY Change 2.38% -86.92% -44.03%
INVESTING ACTIVITIES
Capital Expenditures $168.7K $71.48K $283.2K
YoY Change -253.52%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$168.7K -$71.48K -$283.2K
YoY Change 53.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$372.1K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $274.0K 69.08K $605.0K
YoY Change 39.23% -76.75% -12.59%
NET CHANGE
Cash From Operating Activities -$90.70K -32.20K -$372.0K
Cash From Investing Activities -$168.7K -71.48K -$283.2K
Cash From Financing Activities $274.0K 69.08K $605.0K
Net Change In Cash $14.60K -34.60K -$50.23K
YoY Change -969.05% -167.95%
FREE CASH FLOW
Cash From Operating Activities -$90.70K -$32.20K -$372.0K
Capital Expenditures $168.7K $71.48K $283.2K
Free Cash Flow -$259.4K -$103.7K -$655.2K
YoY Change -1317.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001437517
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
usd
CY2021Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
usd
CY2021Q4 us-gaap Loans Payable Current
LoansPayableCurrent
usd
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
CY2022 CLOQ Loss On Settlement Of Payables
LossOnSettlementOfPayables
usd
CY2021 CLOQ Loss On Settlement With Officer
LossOnSettlementWithOfficer
usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2021 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
usd
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
CY2021 CLOQ Loss On Settlement With Officer And Director
LossOnSettlementWithOfficerAndDirector
usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021 us-gaap Notes Issued1
NotesIssued1
usd
CY2022 CLOQ Common Stock Issued For Accounts Payable
CommonStockIssuedForAccountsPayable
usd
CY2021 CLOQ Beneficial Conversion Feature
BeneficialConversionFeature
usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
usd
CY2022Q4 CLOQ Accumulated Impairment Expense
AccumulatedImpairmentExpense
usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
333-170132
CY2022 dei Entity Registrant Name
EntityRegistrantName
CYBERLOQ TECHNOLOGIES, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity File Number
EntityFileNumber
333-170132
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-2118480
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
4837 Swift Road
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 210-1
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Sarasota
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
34231
CY2022 dei City Area Code
CityAreaCode
612
CY2022 dei Local Phone Number
LocalPhoneNumber
961-4536
CY2022 dei Security12b Title
Security12bTitle
Common Stock
CY2022 dei Trading Symbol
TradingSymbol
CLOQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
119689754 shares
CY2022Q2 dei Entity Public Float
EntityPublicFloat
4668320 usd
CY2022 dei Auditor Firm
AuditorFirmId
5525
CY2022 dei Auditor Name
AuditorName
Fruci & Associates II, PLLC
CY2022 dei Auditor Location
AuditorLocation
Spokane, Washington
CY2022Q4 us-gaap Cash
Cash
4067 usd
CY2021Q4 us-gaap Cash
Cash
54295 usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
53811 usd
CY2021Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
210208 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
57878 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
264503 usd
CY2022Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
283240 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
283240 usd
CY2022Q4 us-gaap Assets
Assets
341118 usd
CY2021Q4 us-gaap Assets
Assets
264503 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
56322 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
43560 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
47737 usd
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
26420 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
35000 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
45000 usd
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
150000 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
150000 usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
2623 usd
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
2088 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
293770 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
264980 usd
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
30362 usd
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
34550 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
30362 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
34550 usd
CY2022Q4 us-gaap Liabilities
Liabilities
324132 usd
CY2021Q4 us-gaap Liabilities
Liabilities
299530 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
119089754 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
119089754 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
82754515 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
82754515 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
119090 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
82755 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
20000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
20000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
30000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
30000 shares
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
20 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
30 usd
CY2022Q4 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
2450000 shares
CY2021Q4 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
8200000 shares
CY2022Q4 CLOQ Shares To Be Issued
SharesToBeIssued
149186 usd
CY2021Q4 CLOQ Shares To Be Issued
SharesToBeIssued
392900 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
50000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7031812 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5743362 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7233122 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6254074 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
16986 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-35027 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
341118 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
264503 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2671 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
197 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
424503 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
468449 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
180063 usd
CY2022 us-gaap Officers Compensation
OfficersCompensation
207000 usd
CY2021 us-gaap Officers Compensation
OfficersCompensation
370400 usd
CY2022 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
1011 usd
CY2021 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
1766 usd
CY2022 CLOQ Rent Expense
RentExpense
9117 usd
CY2021 CLOQ Rent Expense
RentExpense
9031 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24796 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10859 usd
CY2022 us-gaap Supplies Expense
SuppliesExpense
5848 usd
CY2021 us-gaap Supplies Expense
SuppliesExpense
6608 usd
CY2022 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
12733 usd
CY2021 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
13494 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
685008 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
1060670 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-682337 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-1060473 usd
CY2022 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
30786 usd
CY2021 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
20896 usd
CY2021 CLOQ Loss On Settlement Of Payables
LossOnSettlementOfPayables
6343 usd
CY2022 CLOQ Loss On Settlement With Officer
LossOnSettlementWithOfficer
18086 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-195216 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
52623 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-296711 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-27239 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-979048 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1087712 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
98649370 shares
CY2021 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
78428682 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-310023 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
590200 usd
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
470390 usd
CY2021 CLOQ Common Stock Issued For Stock Subscription
CommonStockIssuedForStockSubscription
9218 shares
CY2021 CLOQ Stock Issued During Period Value Issued For Services One
StockIssuedDuringPeriodValueIssuedForServicesOne
107500 usd
CY2021 CLOQ Stock Un Issued During Period Value Stock Subscriptions
StockUnIssuedDuringPeriodValueStockSubscriptions
93000 shares
CY2021 CLOQ Stock Issued During Period Value Other One
StockIssuedDuringPeriodValueOtherOne
92400 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1087712 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-35027 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-35027 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
474261 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
149810 usd
CY2022 CLOQ Common Stock Issued For Settlement Of Debt
CommonStockIssuedForSettlementOfDebt
335000 usd
CY2022 CLOQ Stock Issued During Period Value Other One
StockIssuedDuringPeriodValueOtherOne
12000 usd
CY2022 CLOQ Retirement Of Convertible Debt
RetirementOfConvertibleDebt
50000 usd
CY2022 CLOQ Stock Redeemed During Period Value
StockRedeemedDuringPeriodValue
540000 usd
CY2022 CLOQ Stock Issued During Period Value Preferred Stock Redeemed For Officers Settlement
StockIssuedDuringPeriodValuePreferredStockRedeemedForOfficersSettlement
10 usd
CY2022 CLOQ Reversal Of Common Stock Redeemed For Officers Settlement
ReversalOfCommonStockRedeemedForOfficersSettlement
490000 usd
CY2022 CLOQ Beneficial Conversion Feature Of Convertible Debt
BeneficialConversionFeatureOfConvertibleDebt
60000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-979048 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-979048 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
16986 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
16986 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-979048 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1087712 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
52623 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
350643 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
460708 usd
CY2022 CLOQ Loss On Settlement With Officer And Director
LossOnSettlementWithOfficerAndDirector
18086 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
195216 usd
CY2021 CLOQ Loss On Settlement Of Payable
LossOnSettlementOfPayable
6343 usd
CY2022 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
32436 usd
CY2021 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
2051 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5335 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-62780 usd
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
28288 usd
CY2021 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
20896 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-371963 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-664596 usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
283240 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-283240 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
422075 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
490200 usd
CY2022 CLOQ Proceeds From Issuance Of Commonstock To Be Issued
ProceedsFromIssuanceOfCommonstockToBeIssued
50000 usd
CY2021 CLOQ Proceeds From Issuance Of Commonstock To Be Issued
ProceedsFromIssuanceOfCommonstockToBeIssued
193000 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2100 usd
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
13550 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
125000 usd
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
22500 usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
60000 usd
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
50000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
604975 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
692150 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-50228 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
27554 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
54295 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26741 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4067 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
54295 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
2500 usd
CY2022 us-gaap Notes Issued1
NotesIssued1
141970 usd
CY2022 us-gaap Stock Issued1
StockIssued1
53000 usd
CY2021 us-gaap Stock Issued1
StockIssued1
130140 usd
CY2022 CLOQ Common Stock Issued For Prepaid Expense
CommonStockIssuedForPrepaidExpense
119260 usd
CY2021 CLOQ Common Stock Issued For Prepaid Expense
CommonStockIssuedForPrepaidExpense
537500 usd
CY2021 CLOQ Common Stock Issued For Accounts Payable
CommonStockIssuedForAccountsPayable
5000 usd
CY2022 CLOQ Beneficial Conversion Feature
BeneficialConversionFeature
110000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_843_eus-gaap--UseOfEstimates_zLYLGOAR2MV1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_zHoen9OCSk0b">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing these financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the year reported. Actual results may differ from these estimates. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p>
CY2021Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
0 usd
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
0 usd
CY2020 us-gaap Capitalized Computer Software Impairments1
CapitalizedComputerSoftwareImpairments1
321735 usd
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
283240 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
8418 usd
CY2021 us-gaap Advertising Expense
AdvertisingExpense
5920 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7233122 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-979048 usd
CY2022Q1 us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
10000 shares
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
10 usd
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0 usd
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0 usd
CY2021 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
3000000 shares
CY2022 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
3000000 shares
CY2021Q2 us-gaap Payments For Rent
PaymentsForRent
730 usd
CY2021Q2 us-gaap Payments For Deposits
PaymentsForDeposits
1415 usd
CY2022Q2 us-gaap Payments For Rent
PaymentsForRent
719 usd
CY2022Q1 us-gaap Severance Costs1
SeveranceCosts1
50000 usd
CY2022Q1 CLOQ Gain Loss On Severance Costs
GainLossOnSeveranceCosts
18076 usd
CY2022 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_841_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zV1nfEHyA1Ui" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_868_zrwI5bfdhmW2">Reclassification</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain reclassifications have been made to conform previously reported data to the current presentation. These reclassifications have no effect on our net income (loss) or financial position as previously reported.</span></p>
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
414675 usd
CY2021Q4 CLOQ Accumulated Impairment Expense
AccumulatedImpairmentExpense
321735 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
283240 usd
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
500000 shares
CY2022Q1 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
50000 usd
CY2022Q1 us-gaap Litigation Reserve
LitigationReserve
490000 usd
CY2022 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-540000 usd
CY2022 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
5400000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
26136540 shares
CY2022 CLOQ Common Stock Issued For Settlement Of Debt
CommonStockIssuedForSettlementOfDebt
335000 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-195216 usd
CY2021 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
8000000 shares
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
500000 shares
CY2022Q1 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
50000 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
2088 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
2088 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
2088 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
2088 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
24098 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
32450 usd
CY2020Q2 us-gaap Payments For Rent
PaymentsForRent
426 usd
CY2020Q2 us-gaap Payments For Deposits
PaymentsForDeposits
500 usd
CY2020Q2 us-gaap Payments For Rent
PaymentsForRent
426 usd
CY2020Q3 us-gaap Payments For Rent
PaymentsForRent
639 usd
CY2022 us-gaap Payments For Deposits
PaymentsForDeposits
200 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
35000 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
45000 usd
CY2022Q4 us-gaap Convertible Subordinated Debt Current
ConvertibleSubordinatedDebtCurrent
60000 usd
CY2021Q4 us-gaap Convertible Subordinated Debt Current
ConvertibleSubordinatedDebtCurrent
0 usd
CY2022Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
150000 usd
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
150000 usd
CY2019Q2 us-gaap Repayments Of Debt
RepaymentsOfDebt
5000 usd
CY2019Q3 us-gaap Repayments Of Debt
RepaymentsOfDebt
5000 usd
CY2022Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
30000 usd
CY2022Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
30000 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
6511422 usd
CY2022 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
net operating loss carry forwards begin to expire in 2029.
CY2022 CLOQ Federal Income Tax Benefit Attributable To Net Operating Loss
FederalIncomeTaxBenefitAttributableToNetOperatingLoss
174140 usd
CY2021 CLOQ Federal Income Tax Benefit Attributable To Net Operating Loss
FederalIncomeTaxBenefitAttributableToNetOperatingLoss
92909 usd
CY2022 CLOQ Valuation Allowance
ValuationAllowance
174140 usd
CY2021 CLOQ Valuation Allowance
ValuationAllowance
92909 usd
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1367399 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1177845 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1367399 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1177845 usd

Files In Submission

Name View Source Status
0001493152-23-009418-index-headers.html Edgar Link pending
0001493152-23-009418-index.html Edgar Link pending
0001493152-23-009418.txt Edgar Link pending
0001493152-23-009418-xbrl.zip Edgar Link pending
aud_001.jpg Edgar Link pending
aud_002.jpg Edgar Link pending
cloq-20221231.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
form10-k_htm.xml Edgar Link completed
cloq-20221231_pre.xml Edgar Link unprocessable
cloq-20221231_def.xml Edgar Link unprocessable
cloq-20221231_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cloq-20221231_cal.xml Edgar Link unprocessable